Federal R&D funding expands, but national-security vetting gets opaque power

What it does

The INNOVATE Act expands and restructures the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which provide federal R&D funding to small firms. The bill increases funding allocations, creates a new Phase 1A entry program for first-time applicants, establishes a $30 million 'strategic breakthrough' track for defense contractors, imposes caps on cumulative awards and concurrent proposals, and adds extensive foreign-ownership and national-security vetting requirements. It also mandates performance benchmarks (Phase II conversion ratios) and restricts IP licensing to foreign entities.

Why we flagged it

The bill's primary function is to expand and restructure federal small-business R&D funding while adding extensive foreign-ownership and national-security screening. The strategic breakthrough allocation and performance benchmarks create preferential pathways for defense-aligned firms, making this a hybrid expansion-plus-security-screening measure.

What the text implies

• The 'foreign risk' definition (Section 401) is retroactive (10-year lookback) and extremely broad, capturing co-authorship, licensing agreements, and joint ventures with foreign academics or entities—potentially disqualifying legitimate international research collaborations and chilling academic partnerships.
• Section 402 prohibits agencies from disclosing to applicants that their award was denied due to foreign risk, creating an opaque vetting process where firms cannot contest or cure alleged security concerns, raising due-process concerns.
• The strategic breakthrough allocation (Section 102) requires DoD to award up to $30M per firm with minimal waiver requirements, but only to firms meeting strict criteria (prior Phase II award, $50M cumulative DoD contract cap, 100% matching funds). This creates a narrow, high-value carve-out for venture-backed defense startups.
• Performance benchmarks (Section 501) impose Phase II conversion ratios (0.25–0.5) and revenue thresholds on repeat awardees, potentially excluding academic-focused or pre-commercial firms from continued participation and favoring commercialization-ready incumbents.
• The bill restricts IP licensing to foreign entities for 5–10 years post-award (Section 404), with indefinite extension at agency discretion for 'national security,' creating long-term constraints on firm autonomy and international partnerships.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands access to federal R&D funding for new small-business entrants and rural/emerging-state firms, which is a public benefit. However, it simultaneously imposes significant restrictions on foreign collaboration, IP licensing, and cumulative award eligibility that may chill innovation partnerships and reduce program flexibility for established firms. The national-security vetting regime is opaque and grants agencies broad discretion to deny awards without disclosure, creating asymmetr

Who stands to gain

• venture-backed defense technology startups
• established SBIR/STTR repeat awardees meeting performance benchmarks
• defense contractors and primes with DoD relationships
• domestic-focused small firms in emerging states and rural areas

Named in the bill

Small Business Administration (SBA), Department of Defense (DoD), National Aeronautics and Space Administration (NASA), National Institutes of Health (NIH), Office of Foreign Assets Control (OFAC), Bureau of Industry and Security (BIS), Federal Communications Commission (FCC), U.S. Customs and Border Protection (CBP), Committee on Foreign Investment in the US (CFIUS), White House Office of Science and Technology Policy

Where it stands

• Mar 5, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Mar 5, 2025 — Referred to Senate Committee on Small Business and Entrepreneurship · Congress.gov: “Read twice and referred to the Committee on Small Business and Entrepreneurship”
• Mar 5, 2025 — Hearing held · Congress.gov: “Committee on Small Business and Entrepreneurship. Hearings held”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

10 lobbying clients named this bill on 15 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $1,570,000 in lobbying spend. A filing names 5 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 91% of bills with at least one filing.

Joni Ernst, the sponsor, reported $342,120 in PAC receipts in the 2026 cycle.

• Aerospace Industries Association of America Inc — $800,000 on 1 filing
• University of Michigan — $300,000 on 2 filings
• Lmi Consulting, LLC — $210,000 on 2 filings
• Rise8 — $100,000 on 2 filings
• Activate Global, Inc. — $40,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.